← All patents

US11028083B2

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine …

University of Texas System

Abstract

The present invention relates to ethanediamine-heterocycle compounds that are able to act as inhibitors of PRMTs (protein arginine methyltransferases) for treating cancer and other diseases mediated by PRMTs.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Maria Emilia Di Francesco
Priority date
March 01, 2018
Filing date
March 01, 2019
Grant date
June 08, 2021
Publication date
June 08, 2021
Language
en
Metadata fetched
August 29, 2026 00:28